Our Vision

We envision a future where viral diseases can be rapidly addressed through deep understanding of viral-host metabolism and AI-accelerated drug discovery, dramatically reducing the impact of viral pandemics and chronic post-viral illness.

Strategic Goals

Advance Scientific Understanding

Uncover fundamental mechanisms of viral-host metabolic interactions and post-viral syndrome pathophysiology.

Accelerate Drug Discovery

Develop AI-driven platforms that can identify and optimize antiviral candidates in weeks rather than years.

Translate to Patient Benefit

Move discoveries from bench to bedside through clinical partnerships and industry collaboration.

Train Future Leaders

Develop the next generation of scientists skilled in both experimental and computational approaches.

Measuring Our Impact

  • Publications advancing knowledge of viral metabolism
  • Novel therapeutic candidates entering development
  • Diagnostic biomarkers for post-viral syndromes
  • Trainees launching independent careers
  • Collaborative partnerships established